Share on StockTwits
 

Equities researchers at Argus upped their price target on shares of Perrigo (NASDAQ:PRGO) from $160.00 to $175.00 in a research report issued on Thursday, American Banking & Market News reports. The firm currently has a “buy” rating on the stock. Argus’ price objective indicates a potential upside of 10.97% from the stock’s previous close.

Shares of Perrigo (NASDAQ:PRGO) traded down 0.41% on Thursday, hitting $157.05. 404,148 shares of the company’s stock traded hands. Perrigo has a 52-week low of $98.79 and a 52-week high of $162.35. The stock has a 50-day moving average of $154.6 and a 200-day moving average of $136.. The company has a market cap of $14.810 billion and a P/E ratio of 33.27.

Perrigo (NASDAQ:PRGO) last released its earnings data on Thursday, October 31st. The company reported $1.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.12. The company had revenue of $933.00 million for the quarter, compared to the consensus estimate of $900.10 million. During the same quarter in the previous year, the company posted $1.27 earnings per share. The company’s revenue for the quarter was up 21.3% on a year-over-year basis. On average, analysts predict that Perrigo will post $6.62 earnings per share for the current fiscal year.

Several other analysts have also recently commented on the stock. Analysts at Bank of America Corp. upgraded shares of Perrigo from a “neutral” rating to a “buy” rating in a research note to investors on Tuesday, January 7th. They now have a $171.00 price target on the stock, up previously from $162.00. Separately, analysts at RBC Capital initiated coverage on shares of Perrigo in a research note to investors on Monday, January 6th. They set a “top pick” rating and a $187.00 price target on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Perrigo in a research note to investors on Friday, January 3rd. They now have a $161.00 price target on the stock. Three research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $151.98.

Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (NASDAQ:PRGO) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products and active pharmaceutical ingredients (API).

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.